We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IR:NYSEIngersoll Rand Inc. Analysis

Data as of 2026-06-12 - not real-time

$73.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ingersoll Rand delivered a modest earnings beat with adjusted earnings per share surpassing consensus and revenue growth in the high single‑digits, helped by recent acquisitions while organic sales slipped slightly. The company also announced a multiyear strategic partnership to advance oil‑free compressor technology, which could broaden its addressable market and improve product margins.
However, the stock trades at a valuation that is substantially above both its historical range and industry peers, with a price‑to‑earnings multiple far higher than the sector average and a discounted cash‑flow estimate that suggests a much lower intrinsic price. Technical indicators point to a bearish bias: the short‑term moving average sits below the longer‑term averages, the price is hovering near the upper edge of its recent support zone, and momentum measures are neutral to slightly bearish. High beta and elevated recent volatility add to the downside risk, though the dividend, albeit small, is well covered by cash flow and a modest payout ratio. Overall, the company shows solid operational fundamentals and growth catalysts, but the current market price appears stretched, making the near‑term outlook cautious.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • bearish technical alignment with moving averages
  • price trading well above discounted cash‑flow fair value
  • high volatility and beta amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • earnings beat and incremental revenue from recent acquisitions
  • strategic partnership expanding technology portfolio
  • forward earnings guidance indicating improving profitability

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • sustainable dividend supported by cash flow
  • steady long‑term demand for industrial and precision equipment
  • valuation compression potential as market re‑rates growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin7.54%
P/E Ratio49.5
ROE5.72%
ROA5.12%
Debt/Equity48.35
P/B Ratio2.8
Op. Cash Flow$1.3B
Free Cash Flow$1.0B
Industry P/E30.4

Technical Analysis

TrendBearish
RSI49.6
Support$68.07
Resistance$74.46
MA 20$71.26
MA 50$77.07
MA 200$81.51
MACDBullish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair Value$38.35
Target Price$93.20
Upside/Downside27.32%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%

Risk Assessment

Beta1.45
Volatility34.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.